PTC Therapeutics
PTCT
#3070
Rank
NZ$9.23 B
Marketcap
NZ$110.59
Share price
0.63%
Change (1 day)
5.36%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: NZ$9.23 Billion

As of September 2026 PTC Therapeutics has a market cap of NZ$9.23 Billion. This makes PTC Therapeutics the world's 3070th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$9.23 B-15.25%
2025NZ$10.89 B76.08%
2024NZ$6.18 B88.08%
2023NZ$3.28 B-25.04%
2022NZ$4.38 B6.42%
2021NZ$4.12 B-28.57%
2020NZ$5.77 B30.67%
2019NZ$4.41 B70.59%
2018NZ$2.58 B165.72%
2017NZ$0.97 B80.28%
2016NZ$0.54 B-66.34%
2015NZ$1.60 B-26.14%
2014NZ$2.17 B342.21%
2013NZ$0.49 B

End of Day market cap according to different sources

On Sep 27th, 2026 the market cap of PTC Therapeutics was reported to be:

NZ$9.23 Billion
by Nasdaq info icon info icon
NZ$9.23 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
NZ$487.90 B 5,185.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
NZ$235.35 B 2,449.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$3.12 B-66.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$3.48 B-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.49 B-94.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
NZ$19.85 B 115.07%๐Ÿ‡บ๐Ÿ‡ธ USA